The Food and Drug Administration (FDA) informs the public that the food supplement GINKO BILOBA SOFTGEL CAPSULE has been registered by the Market Authorization Holder, D.B. MANIX INTERNATIONAL, INC.., in accordance to existing FDA rules and regulations.
Accordingly, the list released in FDA Advisory No. 2019-259 is hereby updated to remove the aforementioned food supplement.
The public is advised to always check if a food product is registered with the FDA. The FDA website (www.fda.gov.ph) has a Search feature which may be used by typing in the name of the product before purchasing. Kindly contact the FDA Center for Food Regulation and Research through e-mail at [email protected], or call (02) 857-1900 loc. 8112 or 8105.
To report any sale or distribution of unregistered food products, the online reporting facility, eReport can be accessed at www.fda.gov.ph/ereport.
The public health warning imposed on the remaining product listed in FDA Advisory No. 2019-259 shall remain to be upheld and shall not be affected by the issuance of this advisory. Furthermore, the issuance of this advisory shall not in any manner preclude this Office from issuing subsequent orders it may deem necessary and appropriate, should there be findings of any violation of the company to the existing laws, rules, and regulations.
Dissemination of this advisory to all concerned is hereby requested.
Attachment:FDA Advisory No. 2019-259-A